Follow-up after treatment of gynecologic malignancies

The 5-year survival rate varies greatly depending on the stage, tumor type, differentiation degree and patient’s own physical factors. It is the common wish of doctors and patients to increase the 5-year survival rate and improve the quality of life. It is a common situation in clinical work that patients and their families pay much attention to the initial treatment of the disease, such as surgery, radiotherapy or chemotherapy, but neglect the follow-up and treatment of the disease in the long term. This makes patients’ quality of life decrease and 5-year or long-term survival rate decrease. Therefore, it is very necessary to pay attention to the long-term follow-up of malignant tumors. The following are the specific requirements for follow-up after treatment of various gynecological tumors. 1.Cervical cancer The recurrence of this disease is 50% within 1 year and 75%~80% within 2 years after treatment, so it should be reviewed once every 3 months within 2 years after treatment, once every 6 months within 3~5 years, and once a year from the sixth year. 2.Endometrial cancer 75%~95% of recurrence is within 2~3 years after surgery, so generally follow up every 3 months for 2~3 years after surgery, every 6 months after 3 years, and once a year after 5 years. 3.Ovarian cancer Once a month in 1 year after surgery, once every 3 months in 2 years after surgery, once every 4~6 months in 3~5 years after surgery depending on the condition, and once a year after 5 years. 4.Gestational trophoblastic tumor The first time is 3 months after discharge, then once every 6 months to 3 years, then once a year to 5 years, and then may be once every 2 years. Strict contraception during the follow-up period, and pregnancy is usually not allowed until 12 months or more after the cessation of chemotherapy. The follow-up is based on blood HCG as the main monitoring indicator, combined with ultrasound CT and MRI if necessary. In addition, the follow-up of the patient’s quality of life, which is defined by WHO as “the individual’s perception of his or her status in life in relation to his or her goals, aspirations, standards and concerns, within the context of the culture and value system in which he or she lives”, should be of common concern to both doctors and patients. “. Patients’ non-therapeutic needs such as depression, fear of recurrence, chronic physical pain, infertility and sexual dysfunction, family expense difficulties and unemployment are relatively obvious after the “robbery”. Therefore, strengthening quality of life follow-up, improving clinical oncologists’ ability of emotional and psychological analysis, and mastering the skills of establishing information exchange and patient education with patients are new requirements for clinicians. After treatment of various malignant tumors, we must pay attention to follow-up, insist on early diagnosis and early treatment, and follow the principle of individualization. The smaller the lesion and the lighter the symptoms, the better the efficacy of treatment.